NexImmune (NEXI) Institutional Ownership → This is the best new way to score with AI (From Weiss Ratings) (Ad) Free NEXI Stock Alerts $3.47 +0.07 (+2.06%) (As of 12:03 PM ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for NexImmune (NASDAQ:NEXI)CurrentInstitutional OwnershipPercentage9.85%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$8.79MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$673.55K Get NEXI Insider Trade Alerts Want to know when executives and insiders are buying or selling NexImmune stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NEXI Institutional Buying and Selling by Quarter Ad Monetary GoldTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. NexImmune Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails3/22/2024 PNC Financial Services Group Inc.12,640$28K0.0%-96.0%1.192% 5/16/2023Slate Path Capital LP925,000$352K0.0%N/A3.547% 4/26/2023 Caprock Group LLC103,482$39K0.0%+82.9%0.397% 4/14/2023 Raymond James & Associates320,622$122K0.0%+947.0%1.229% 11/15/2022First Manhattan Co.66,214$36K0.0%-27.4%0.274% 8/15/2022Kettle Hill Capital Management LLC272,447$439K0.1%N/A1.193% Get the Latest News and Ratings for NEXI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NexImmune and its competitors with MarketBeat's FREE daily newsletter. 7/27/2022 Bailard Inc.20,285$33K0.0%N/A0.089% 5/10/2022 Smith Salley & Associates11,000$46K0.0%N/A0.048% 4/12/2022 CAPROCK Group Inc.56,582$238K0.0%N/A0.248% 2/11/2022M28 Capital Management LP133,442$615K0.5%N/A0.588% 2/9/2022First Republic Investment Management Inc.100,000$461K0.0%N/A0.440% 2/4/2022 TimesSquare Capital Management LLC216,391$998K0.0%-52.4%0.953% 2/2/2022 New York State Common Retirement Fund9,259$43K0.0%+60.5%0.041% 11/17/2021ArrowMark Colorado Holdings LLC1,958,813$29.66M0.2%-23.1%8.625% 11/16/2021Suvretta Capital Management LLC344,223$5.21M0.1%-5.9%1.521% 11/16/2021Metropolitan Life Insurance Co NY5,828$88K0.0%N/A0.026% 11/15/2021683 Capital Management LLC100,687$1.52M0.1%+67.8%0.445% 11/15/2021Kingdon Capital Management L.L.C.117,962$1.79M0.2%N/A0.521% 11/15/2021First Manhattan Co.147,159$2.23M0.0%N/A0.650% 11/12/2021Rockefeller Capital Management L.P.27,860$421K0.0%N/A0.123% 11/12/2021The Manufacturers Life Insurance Company10,464$158K0.0%N/A0.046% 11/12/2021 Geode Capital Management LLC212,431$3.22M0.0%+87.4%0.939% 11/12/2021Edgewood Management LLC56,015$848K0.0%N/A0.248% 11/10/2021 Citigroup Inc.3,335$50K0.0%+935.7%0.015% 11/9/2021 BlackRock Inc.812,664$12.30M0.0%+150.4%3.591% 11/8/2021 TimesSquare Capital Management LLC454,550$6.88M0.1%-5.7%2.009% 11/4/2021Deutsche Bank AG10,149$154K0.0%+159.6%0.045% 11/2/2021 Raymond James & Associates25,957$393K0.0%N/A0.115% 11/1/2021 SG Americas Securities LLC7,524$114K0.0%N/A0.033% 8/17/2021Walleye Capital LLC32,140$525K0.0%-19.7%0.142% 8/17/2021ArrowMark Colorado Holdings LLC2,547,993$2.13M0.0%-1.7%11.260% 8/16/2021Alyeska Investment Group L.P.11,417$186K0.0%-84.8%0.050% 8/16/2021 Charles Schwab Investment Management Inc.41,670$681K0.0%-7.0%0.184% 8/16/2021State Street Corp95,714$1.56M0.0%+97.5%0.423% 8/13/2021Northern Trust Corp68,941$1.13M0.0%-1.3%0.305% 8/13/2021 Geode Capital Management LLC113,336$1.85M0.0%+11.1%0.501% 8/13/2021 Vanguard Group Inc.361,278$5.90M0.0%+75.2%1.597% 8/12/2021 JPMorgan Chase & Co.273,434$4.46M0.0%+69.2%1.211% 8/11/2021 Bank of New York Mellon Corp18,240$298K0.0%+31.0%0.081% 8/11/2021 BlackRock Inc.324,524$5.30M0.0%+6.9%1.437% This is the best new way to score with AI (Ad)If you thought that you missed your chance to score big on AI, I have great news. A rare second profit window is starting to open.Click now for the best way into the newest AI projects8/9/2021 TimesSquare Capital Management LLC482,100$7.87M0.1%-1.0%2.135% 8/4/2021 Russell Investments Group Ltd.2,432$39K0.0%N/A0.011% 5/18/2021Baker BROS. Advisors LP294,117$5.61M0.0%N/A1.292% 5/18/2021Millennium Management LLC105,407$2.01M0.0%N/A0.463% 5/18/2021Alyeska Investment Group L.P.75,000$1.43M0.0%N/A0.330% 5/18/2021Jane Street Group LLC13,226$252K0.0%N/A0.058% 5/18/2021California State Teachers Retirement System9,656$184K0.0%N/A0.042% 5/17/2021Suvretta Capital Management LLC579,283$11.05M0.2%N/A2.545% 5/17/2021Walleye Capital LLC40,000$763K0.0%N/A0.176% 5/17/2021683 Capital Management LLC60,000$1.15M0.1%N/A0.264% 5/17/2021HBK Investments L P30,000$572K0.0%N/A0.132% 5/17/2021 Allen Operations LLC635,934$12.13M2.5%N/A2.794% 5/17/2021DSAM Partners London Ltd89,500$1.71M0.3%N/A0.393% 5/17/2021 Nuveen Asset Management LLC10,368$198K0.0%N/A0.046% 5/14/2021Bridger Management LLC400,000$7.63M0.7%N/A1.758% 5/13/2021 Bank of New York Mellon Corp13,925$266K0.0%N/A0.061% 5/12/2021Northern Trust Corp69,871$1.33M0.0%N/A0.307% 5/12/2021 Geode Capital Management LLC101,977$1.95M0.0%N/A0.448% 5/12/2021 JPMorgan Chase & Co.161,640$3.08M0.0%N/A0.710% 5/12/2021 UBS Group AG1,883$36K0.0%N/A0.008% 5/12/2021 TimesSquare Capital Management LLC487,100$9.29M0.1%N/A2.140% 5/11/2021 New York State Common Retirement Fund5,700$109K0.0%N/A0.025% 5/7/2021 BlackRock Inc.303,497$5.79M0.0%N/A1.334% 5/7/2021 American International Group Inc.3,731$71K0.0%N/A0.016% 5/4/2021 Victory Capital Management Inc.11,045$211K0.0%N/A0.049% (Data available from 1/1/2016 forward) NEXI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NEXI shares? During the previous two years, the following institutional investors and hedge funds held shares of NexImmune shares: Kettle Hill Capital Management LLC ($439K), Slate Path Capital LP ($352K), Raymond James & Associates ($122K), Caprock Group LLC ($39K), First Manhattan Co. ($36K), and Bailard Inc. ($33K), and PNC Financial Services Group Inc. ($28K).Learn more on NEXI's institutional investors. What percentage of NexImmune stock is owned by institutional investors? 9.85% of NexImmune stock is owned by institutional investors. Learn more on NEXI's institutional investor holdings. Which institutional investors have been buying NexImmune stock? The following institutional investors have purchased NexImmune stock in the last 24 months: Slate Path Capital LP ($925K), Raymond James & Associates ($290K), Kettle Hill Capital Management LLC ($272.45K), Caprock Group LLC ($46.90K), and Bailard Inc. ($20.29K). How much institutional buying is happening at NexImmune? Institutional investors have bought a total of 1,554,632 shares in the last 24 months. This purchase volume represents approximately $23.77M in transactions. Which NexImmune major shareholders have been selling company stock? The following institutional investors have sold NexImmune stock in the last 24 months: PNC Financial Services Group Inc. ($303.40K), and First Manhattan Co. ($25K). How much institutional selling is happening at NexImmune? Institutional investors have sold a total of 328,399 shares in the last 24 months. This volume of shares sold represents approximately $1.02M in transactions. Related Companies: Seelos Therapeutics Institutional Ownership ZyVersa Therapeutics Institutional Ownership Kazia Therapeutics Institutional Ownership Petros Pharmaceuticals Institutional Ownership Bright Minds Biosciences Institutional Ownership Genprex Institutional Ownership Cingulate Institutional Ownership GT Biopharma Institutional Ownership Sonnet BioTherapeutics Institutional Ownership Exicure Institutional Ownership This page (NASDAQ:NEXI) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBill Clinton Backing Biden Replacement???The Freeport SocietyTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingTop 5 Tech Stocks to Buy for 2024Daily Market AlertsTop 5 AI Stocks to Buy for 2024Market Moving TrendsHow to Play the AI and Crypto Markets in One SwingWeiss Ratingsis this a buy and hold stock?Tips4Traders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexImmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
